| Dr Wesley O'neal Harris, PHARMD, AAHIVE | |
|
13620 Highway 43 N, Northport, AL 35475-4580 | |
| (205) 333-0321 | |
| Not Available |
| Full Name | Dr Wesley O'neal Harris |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 13620 Highway 43 N, Northport, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497354245 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PHA.0022746 (Colorado) | Secondary |
| 183500000X | Pharmacist | 21044 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wesley O'neal Harris, PHARMD, AAHIVE 841 Gibbs Rd, Pike Road, AL 36064-2408 Ph: (334) 414-1030 | Dr Wesley O'neal Harris, PHARMD, AAHIVE 13620 Highway 43 N, Northport, AL 35475-4580 Ph: (205) 333-0321 |
News Archive
Access to antiretroviral therapy for advanced HIV infection in low- and middle-income countries continued to grow throughout 2006, with more than 2 million people living with HIV/AIDS receiving treatment in December 2006, a 54% increase over the 1.3 million people on treatment one year earlier in these countries.
Both Asia and Africa are home to many plants that can be used for the treatment of many diseases and their medicinal properties are gaining interest in western societies.
Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease.
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
In a decision of importance to the case at hand and all cases involving claims of attorney-client or work product privilege, the Honorable Cynthia M. Rufe of the United States District Court for the Eastern District of Pennsylvania, in a decision of December 7, 2009, has ruled that GlaxoSmithKline (GSK), the manufacturer of the prescription diabetes medication Avandia, must produce dozens of documents that it withheld on claims of privilege.
› Verified 5 days ago
Daniel Lee Webber, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 Fax: 205-333-1544 | |
Dr. Jessica Jo Salvatore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5710 Mcfarland Blvd, Northport, AL 35476 Phone: 205-333-7873 | |
Nicholas Matthew Witucki, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 | |
Casey Rasinen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 | |
Dr. Zachary Grant Hunt, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3107 Lurleen B Wallace Blvd, Northport, AL 35476 Phone: 205-333-9343 | |
Jann Sides, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 Mcfarland Blvd, Northport, AL 35476 Phone: 205-339-0155 Fax: 205-339-1316 | |
Dr. Robert Meaders Bragg, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2300 Mcfarland Blvd, Northport, AL 35476 Phone: 205-339-2700 |